Lamotrigine treatment of aggression in female borderline patients, Part II: An 18-month follow-up

Journal of Psychopharmacology

Volumn 22, Issue 7, 2008, Pages 805-808

  Leiberich, P ^a   Nickel, M K ^b,e   Tritt, K ^c   Gil, F Pedrosa ^d  

^a Inntalklink ^*  (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e Clinic for Psychosomatic Medicine and Psychotherapy   (Austria)

Author keywords

Aggression; Borderline personality disorder; Lamotrigine

Indexed keywords

LAMOTRIGINE; PLACEBO;

AGGRESSION; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LONG TERM CARE; NAUSEA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RASH; SIDE EFFECT; STATE-TRAIT ANGER EXPRESSION INVENTORY; WEIGHT REDUCTION;

ADULT; AGGRESSION; ANTIMANIC AGENTS; BORDERLINE PERSONALITY DISORDER; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; TRIAZINES;

EID: 50249099306     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107084004     Document Type: Article

References (17)

1. Azouvi P., Jokic C., Attal N., Denys P., Markabi S., Bussel B. (1999) Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Inj 13: 797-804
2. Calabrese J.R. (2003) 16th Congress of European College of Neuropsychopharmacology [ECPN). Prag 20-24 September
3. Dufner J., Jensen U., Schumacher E. (1992) Statistik mit SAS. Teubner, Stuttgart
4. Fava M. (1997) Psychopharmacologic treatment of pathologic aggression. Psychiatry Clin North Am 20: 427-431
5. Loew T., Nickel M., Kaplan P., Nickel C., Muehlbacher M., Kettler C., Lahmann C., Buschmann W., Tritt K., Leiberich P., Rother W., Egger C. (2006) Topiramate treatment of women with borderline personality disorder: a double-blind, placebo-controlled study. J Clin Psychopharmacol 26: 61-66
6. Messenheimer J., Mullens E.L., Giorgi L., Young F. (1998) Safety review of adult clinical trial experience with lamotrigine. Drug Saf 18: 281-296
7. Nickel M.K., Nickel C., Mitterlehner F.O., Tritt K., Lahmann C., Leiberich P.K., Rother W., Loew T. (2004) Topiramate treatment of aggression in female borderline personality disorder patients: a double blind, placebo-controlled study. J Clin Psychiatry 65: 1515-1519
8. Nickel M., Nickel C., Kaplan P., Lahmann C., Muehlbacher M., Tritt K., Rother W., Loew T. (2005) Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study. Biol Psychiatry 57: 495-499
9. Nickel M., Muehlbacher M., Nickel C., Kettler C., Pedrosa Gil F., Bachler E., Buschmann W., Rother N., Fartacek R., Egger C., Anvar J., Rother W., Loew T., Kaplan P. (2006) Aripiprazole in treatment of borderline patients: a double-blind, placebo-controlled study. Am J Psychiatry 163: 833-838
10. Pinto O.C., Akiskal H.S. (1998) Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder. J Affect Disord 51: 333-343
11. Preston G.A., Marchant B.K., Reimherr F.W., Strong R.E., Hedges D.W. (2004) Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 79: 297-303
12. Rizvi S.T. (2002) Lamotrigine and borderline personality disorder. J Child Adol Psychopharmacol 12: 365-366
13. Schwenkmezger P., Hodapp V., Spielberger C.D. (1992) Das State-Trait-Aergerausdrucks-Inventar. Huber, Bern, Goettingen, Toronto
14. Stevens J. (1992) Applied multivariate statistics for the social sciences. Erlbaum, New Jersey
15. Tariot P.N., Erb R., Podgorski C.A., Cox C., Patel S., Jakimovich L. (1998) Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155: 54-61
16. Tritt K., Nickel C., Mitterlehner F., Tritt K., Lahmann C., Leiberich P., Rother W., Loew T., Nickel M. (2005) Lamotrigine treatment of aggression in female Borderline Personality Disorder Patients: A double-blind, placebo-controlled study. J Psychopharmacol 19: 287-291
17. Zanarini M. (2004) Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep 6: 66-70